Cyclerion Therapeutics Inc.
13F holders, Q2 2024 (June 30)17holders +2
3new positions
2sold out
$2.29avg. 13F price*
At the end of Q2 2024, 17 institutions reported holding Cyclerion Therapeutics Inc. in their 13F filings, up 2 from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were Slate Path Capital LP ($823K), MFN Partners Management, LP ($386K) and Tyndall Capital Partners L P ($379K).
- Company
- Cyclerion Therapeutics Inc.
- CUSIP
- 23255M204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $272 |
| Exits | 2 | $48 |
All 13F filers, Q1 2024 → Q2 2024: 3,691 shares bought and 22,235 shares sold, net −18,544 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Slate Path Capital LP | 0.02% | No change | 357,880 | $823K |
| MFN Partners Management, LP | 0.01% | No change | 169,460 | $386K |
| Tyndall Capital Partners L P | 100.00% | No change | 164,777 | $379K |
| FMR LLC | 0.00% | Reduce -0.6% | 161,419 | $368K |
| Artal Group S.A. | 0.01% | Reduce -15.3% | 117,643 | $271K |
| Geode Capital Management, LLC | 0.00% | Add +5.9% | 33,978 | $77K |
| Vanguard Group Inc. | 0.00% | No change | 23,490 | $54K |
| BlackRock Inc. | 0.00% | No change | 17,169 | $39K |
| UBS Group AG | 0.00% | Add +7.2% | 2,706 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +4336.4% | 1,464 | $3K |
| Morgan Stanley | 0.00% | No change | 649 | $1K |
| Group One Trading LLC | 0.00% | No change | 540 | $1K |
| Royal Bank of Canada | 0.00% | Add +18.2% | 416 | $1K |
| Activest Wealth Management | 0.00% | New | 100 | $230 |
| Bank of America Corp. | 0.00% | New | 16 | $37 |
| PNC Financial Services Group, Inc. | 0.00% | New | 2 | $5 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CYCLERION THERAPEUTICS INC's weight in each manager's 13F, not the share of Cyclerion Therapeutics Inc. the manager owns.